The Food & Drug Administration is warning healthcare providers to be on the lookout for fake surgical mesh products that ape C.R. Bard’s (NYSE:BCR) Davol Inc. brand, saying hospitals and surgical centers — not to mention patients with surgical mesh implants — should be especially vigilant.
The federal watchdog agency said four sizes of the counterfeit flat sheet polypropylene surgical mesh have been pegged by the FDA and Bard so far:
- 0112650 – Bard Flat Mesh 2” x 4”: Lots 43APD007 and 48HVS036;
- 0112660 – Bard Flat Mesh 10” x 14”: Lots HURL0336 and HUSD0629;
- 0112680 – Bard Flat Mesh 3” x 6”: Lots 43HPD027, 43HPD032, HUSG0540, 43HDP027, HUSE0532, 43LPD507, HUSF0763, 43IOD011 and 43IPD038;
- 0112720 – Bard Flat Mesh 6” x 6”: Lot 43FQD327.
Transforming Patient Care: The Role of AI-Powered Assistants
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
The FDA is recommending that healthcare professionals refrain from using any of the fake lots and take a close look at their surgical mesh inventories to weed out any of the identified fakes and report other suspicious-looking products. Any truly ersatz or suspected counterfeit mesh products should be reported to Bard by calling (800) 556-6275 and to the FDA’s Office of Criminal Investigations by calling (800) 551-3989 or visiting http://www.fda.gov/OCI1.
The agency said it is still investigating the fake mesh to determine the extent of the risk to public health and to pin down the culprits. It’s unclear whether the counterfeits meet the authentic product’s specifications for strength, sterility or clinical performance.
Reducing Clinical and Staff Burnout with AI Automation
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Chris Seper runs MedCityNews.com and contributes regularly to the site. He is the vice president of healthcare for Breaking Media, MedCity's corporate owners. Reach him at [email protected].
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.